PharmaShots | Incisive News in 3 Shots

Subscribe Now

HER2-Positive Early Stage Breast Cancer

Tanvex Presents Results of TX05 (biosimilar- trastuzumab) in P-III Study for the Treatment of HER2-Positive Early Stage Breast Cancer at ESMO 2021

Tanvex Presents Results of TX05 (biosimilar- trastuzumab) in P-III Study for the Treatment of HER2-Positive Early Stage Breast Can...

September 20, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us